Structural and Antitumor Properties of the YSNSG Cyclopeptide Derived from Tumstatin

Chemistry and Biology

Volumn 13, Issue 12, 2006, Pages 1307-1315

  Thevenard, Jessica ^a   Floquet, Nicolas ^b   Ramont, Laurent ^a   Prost, Elise ^b   Nuzillard, Jean Marc ^b   Dauchez, Manuel ^a   Yezid, Hocine ^b   Alix, Alain J P ^b   Maquart, François Xavier ^a   Monboisse, Jean Claude ^a   Brassart Pasco, Sylvie ^a  

^a CNRS   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

CELLCYCLE; CHEMBIO

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOANTIGEN; COLLAGEN TYPE 4; CYCLOPEPTIDE; TYPE IV COLLAGEN ALPHA3 CHAIN; YSNSG CYCLOPEPTIDE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL MOTION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; LUNG TUMOR; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN CONFORMATION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTOANTIGENS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CIRCULAR DICHROISM; COLLAGEN TYPE IV; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; PEPTIDES, CYCLIC; PROTEIN CONFORMATION;

EID: 33845565357     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2006.10.007     Document Type: Article

References (31)

1. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
2. Hofmann U.B., Houben R., Bröcker E.B., and Becker J.C. Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 87 (2005) 307-314
3. Itoh Y., and Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell. Physiol. 206 (2006) 1-8
4. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett. 194 (2003) 1-11
5. Brooks P.C., Stromblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., Quigley J.P., and Cheresh D.A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin α v β 3. Cell 85 (1996) 683-693
6. Andreasen P.A., Egelund R., and Petersen H.H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci. 57 (2000) 25-40
7. Monea S., Lehti K., Keski-Oja J., and Mignatti P. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. J. Cell. Physiol. 192 (2002) 160-170
8. Sado Y., Kagawa M., Naito I., Ueki Y., Seki T., Momota R., Oohashi T., and Ninomiya Y. Organization and expression of basement membrane collagen IV genes and their roles in human disorders. J. Biochem. (Tokyo) 123 (1998) 767-776
9. Ortega N., and Werb Z. New functional roles for non-collagenous domains of basement membrane collagens. J. Cell Sci. 115 (2002) 4201-4214
10. Maeshima Y., Colorado P.C., Torre A., Holthaus K.A., Grunkemeyer J.A., Ericksen M.B., Hopfer H., Xiao Y., Stillman I.E., and Kalluri R. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J. Biol. Chem. 275 (2000) 21340-21348
11. Pasco S., Han J., Gillery P., Bellon G., Maquart F.X., Borel J.P., Kefalides N.A., and Monboisse J.C. A specific sequence of the noncollagenous domain of the α3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells. Cancer Res. 60 (2000) 467-473
12. Floquet N., Pasco S., Ramont L., Derreumaux P., Laronze J.Y., Nuzillard J.M., Maquart F.X., Alix A.J.P., and Monboisse J.C. The antitumor properties of the α3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent. J. Biol. Chem. 279 (2004) 2091-2100
13. Fuchs P.F.J., and Alix A.J.P. High accuracy prediction of β-turns and their types using propensities and multiple alignments. Proteins 59 (2005) 828-839
14. Essmann U., Perera L., Berkowitz M.L., Darden T., Lee H., and Pedersen L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 103 (1995) 8577-8593
15. Humphrey W., Dalke A., and Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 14 (1996) 33-38 27-28
16. Pasco S., Monboisse J.C., and Kieffer N. The α3(IV)185-206 peptide from noncollagenous domain 1 of type IV collagen interacts with a novel binding site on the β3 subunit of integrin αVβ3 and stimulates focal adhesion kinase and phosphatidylinositol 3-kinase phosphorylation. J. Biol. Chem. 275 (2000) 32999-33007
17. Sato H., Takino T., and Miyamori H. Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis. Cancer Sci. 96 (2005) 212-217
18. Kim J., Hong S.Y., Park H.S., Kim D.S., and Lee W. Structure and function of RGD peptides derived from disintegrin proteins. Mol. Cells 19 (2005) 205-211
19. Buerkle M.A., Pahernik S.A., Sutter A., Jonczyk A., Messmer K., and Dellian M. Inhibition of the α-V integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo. Br. J. Cancer 86 (2002) 788-795
20. Haier J., Goldmann U., Hotz B., Runkel N., and Keilholz U. Inhibition of tumor progression and neoangiogenesis using cyclic RGD-peptides in a chemically induced colon carcinoma in rats. Clin. Exp. Metastasis 19 (2002) 665-672
21. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., and Karplus M. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4 (1983) 187-217
22. MacKerell Jr. A.D., Bashford D., Bellott M., Dunbrack Jr. R.L., Evanseck J.D., Field M.J., Fischer S., Gao J., Guo H., Ha S., et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 102 (1998) 3586-3616
23. 3JHN α for identification of helical secondary structure. J. Mol. Biol. 180 (1984) 741-751
24. Ferrara P., Apostolakis J., and Caflisch A. Evaluation of a fast implicit solvent model for molecular dynamics simulations. Proteins 46 (2002) 24-33
25. Lazaridis T., and Karplus M. Effective energy function for proteins in solution. Proteins 35 (1999) 133-152
26. Phillips J.C., Braun R., Wang W., Gumbart J., Tajkhorshid E., Villa E., Chipot C., Skeel R.D., Kale L., and Schulten K. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26 (2005) 1781-1802
27. Kalé L., Skeel R., Bhandarkar M., Brunner R., Gursoy A., Krawetz N., Phillips J., Shinozaki A., Varadarajan K., and Schulten K. NAMD2: greater scalability for parallel molecular dynamics. J. Comput. Phys. 151 (1999) 283-312
28. Kelley L.A., Gardner S.P., and Sutcliffe M.J. An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. Protein Eng. 9 (1996) 1063-1065
29. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
30. Pasco S., Ramont L., Venteo L., Pluot M., Maquart F.X., and Monboisse J.C. In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model. Exp. Cell Res. 301 (2004) 251-265
31. Wald M., Olejar T., Sebkova V., Zadinova M., Boubelik M., and Pouckova P. Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16. Cancer Chemother. Pharmacol. Suppl. 47 (2001) S16-S22